The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease

Nephrology Dialysis Transplantation

Volumn 15, Issue 6, 2000, Pages 836-839

  Van Dijk, Marjan A ^a   Breuning, Martijn H ^a   Peters, Dorien J M ^a   Chang, Peter C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ACE insertion deletion polymorphism; Dominant polycystic kidney disease; Progression

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0034022831     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.6.836     Document Type: Article

References (31)

1. Gabow PA. Autosomal dominant polycystic kidney disease. Am J Kidney Dis 1993; 22: 511-522
2. Peters DJ, Sandkuijl LA. Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 1992; 97: 128-139
3. Hateboer N, Van Dijk MA, Dogdanova N et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 1999; 353: 103-107
4. Milutinovic J, Rust PF, Fialkow PJ et al. Intrafamilial phenolypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis 1992; 19: 465-472
5. Peral B, Ong ACM, San Millan JL, Gamble V, Rees L. A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD1). Hum Mol Genet 1996; 5: 539-542
6. Gabow PA, Johnson AM, Kaehny WD et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 1992; 41: 1311-1319
7. Harrap SB, Davidson HR, Conner JM et al. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21: 455-460
8. Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. Kidney Int 1994; 46: 1118-1123
9. Tiret L, Rigat B. Viskivis S et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205
10. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Laouel J-M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1992; 1: 72-75
11. Fornage M, Amos CI, KardiaS, Sing CF, Turner ST, Boerwinkle E. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 1998; 97: 1773-1779
12. O'Donnell C, Lindpainter K, Larson MG et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham heart study. Circulation 1998; 97: 1766-1772
13. Beohar N, Damaraju S, Prather A et al. Angiotensin-1 converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med 1995; 43: 275-280
14. Raynolds MV, Bristow MR, Bush E et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-1075
15. Harden PN, Geddes C, Rowe PA et al. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995; 345: 1540-1542
16. Lee DY, Kim W, Kang SK, Koh GY, Park SK. Angiotensin-converting enzyme gene polymorphism in patients with minimal-change nephrotic syndrome and focal segmental glomerulosclerosis. Nephron 1997; 77: 471-473
17. Miller SA, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nuleic Acids Res 1988; 16: 3
18. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DPC1) (dipeptidyl carboxypeptidase). Nucleic Acids Res 1992; 20: 1433
19. Shanmugam V, Sell KW, Saha BK. Mistyping ACH heterozygotes. PCR Methods Appl 1993; 3: 120-121
20. Baboolal K, Ravine D, Daniels J et al. Association of the angiotensin 1 converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 1997; 52: 607-613
21. Perez-Oller L, Torra R, Badenas C, Mila M, Darnell A. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1999; 34: 273-278
22. Gonzalo A, Gallego A, Tato A, Ortuno J. Age at renal replacement therapy in autosomal dominant polycystic kidney disease. Nephron 1996; 74: 620
23. Choukroun G, Itakura Y, Albouze G et al. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995; 6: 1634-1642
24. Gonzalo A, Gallego A, Rivera M, Orte L, Ortuno J. Influence of hypertension on early renal insulliciency in autosomal dominant polycyslic kidney disease. Nephron 1996; 72: 225-230
25. Marcelli D, Locatelli F, Alberti D et al. Hypertension as a factor in chronic renal insufficiency progression in polycystic kidney disease. Nephrol Dial Transplant 1995; 10 [Suppl. 6]: 15-17
26. Sedman A, Bell P, Manco-Johnson M et al. Autosomal dominant polycystic kidney disease in childhood: a longitudinal study. Kidney Int 1987; 31: 1000-1005
27. Zeier M, Geberth S, Schmidt KG, Mandelbaum A, Ritz E. Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1993; 3: 1451-1457
28. Maschio G, Alberti D, Janin G et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-945
29. Klahr S, Breyer JA, Beck GJ et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. J Am Soc Nephrol 1995; 5: 2037-2047
30. VanDijk MA, Peters DJ, Breuning MH, Chang PC. The angiotensin converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1999; 10: 1916-1920
31. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996; 87: 979-987